BridgeBio Pharma, Inc. ($BBIO)
Valantine Hannah โ Director
Shares
25,484
Price
$0.00
Total Value
$0.00
Nearby Earnings
Feb 19, 2026
EPS:Est: -0.74
Revenue:Est: $149.07M
Feb 24, 2026
EPS:Est: -0.75
Revenue:Est: $149.07M
Transaction Details
| Insider | Valantine Hannah |
|---|---|
| Title | Director |
| Transaction Date | Feb 27, 2026 |
| Expiration Date | Oct 24, 2031 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Disposed |
| Security | Stock Option (Right to Buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Mar 3, 2026 |
| Shares Purchased | 25,484 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Derivative | Derivative |
| Accession Number | 0001470831-26-000236 |
| Document | View SEC Filing |